VIRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.42%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $21,782.50

Viracta Therapeutics Insider Trading History Chart

Viracta Therapeutics Share Price & Price History

^$0.49

+0.30 (1.20%)

As of 12/1/2023 01:00 AM ET

Days: 30 | 90 | 365

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

Viracta Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/28/2023	Daniel R. Chevallard	CFO	Sell	3,720	$0.50	$1,860.00	98,822
8/28/2023	Daniel R. Chevallard	CFO	Sell	3,512	$1.45	$5,092.40	95,653
5/25/2023	Daniel R. Chevallard	CFO	Sell	3,635	$1.42	$5,161.70	92,277
2/27/2023	Daniel R. Chevallard	CFO	Sell	3,599	$1.68	$6,046.32	89,023
2/27/2023	Lisa Rojkjaer	Insider	Sell	2,156	$1.68	$3,622.08	48,087
11/28/2022	Daniel R. Chevallard	CFO	Sell	3,532	$2.72	$9,607.04	85,733
11/28/2022	Lisa Rojkjaer	Insider	Sell	2,116	$2.72	$5,755.52	46,116
8/26/2022	Daniel R. Chevallard	CFO	Sell	3,655	$4.02	$14,693.10	82,376
8/26/2022	Ivor Royston	CEO	Sell	13,379	$4.01	$53,649.79	612,770
8/26/2022	Lisa Rojkjaer	Insider	Sell	2,190	$4.01	$8,781.90	44,105
5/26/2022	Daniel R. Chevallard	CFO	Sell	3,596	$1.90	$6,832.40	79,142
5/26/2022	Ivor Royston	CEO	Sell	13,162	$1.90	$25,007.80	600,930
5/26/2022	Lisa Rojkjaer	Insider	Sell	2,154	$1.90	$4,092.60	42,168
2/28/2022	Daniel R. Chevallard	CFO	Sell	3,998	$2.78	$11,114.44
2/28/2022	Ivor Royston	CEO	Sell	14,635	$2.78	$40,685.30
2/28/2022	Lisa Rojkjaer	Insider	Sell	2,395	$2.78	$6,658.10
11/29/2021	Daniel R. Chevallard	CFO	Sell	4,325	$4.82	$20,846.50
11/29/2021	Ivor Royston	CEO	Sell	15,833	$4.82	$76,315.06
11/29/2021	Lisa Rojkjaer	Insider	Sell	2,591	$4.82	$12,488.62
11/26/2021	Daniel R. Chevallard	CFO	Sell	3,254	$4.80	$15,619.20
11/26/2021	Ivor Royston	CEO	Sell	11,914	$4.80	$57,187.20
11/26/2021	Lisa Rojkjaer	Insider	Sell	1,950	$4.80	$9,360.00
11/15/2021	Ivor Royston	CEO	Buy	8,000	$5.56	$44,480.00

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Viracta Therapeutics (NASDAQ:VIRX)

25.84% of Viracta Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Viracta Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/13/2023	Acadian Asset Management LLC	97,109	$99K	0.0%	-42.1%	0.252%
8/11/2023	Renaissance Technologies LLC	134,799	$0.19M	0.0%	+7.6%	0.350%
8/11/2023	BlackRock Inc.	460,235	$0.65M	0.0%	+2.8%	1.196%
8/7/2023	Acadian Asset Management LLC	167,818	$0.24M	0.0%	+74.6%	0.436%
8/2/2023	MAI Capital Management	307,570	$0.43M	0.0%	-18.9%	0.800%
7/20/2023	Bailard Inc.	47,700	$67K	0.0%	+139.7%	0.124%
5/16/2023	Jane Street Group LLC	55,465	$88K	0.0%	+129.2%	0.144%
5/15/2023	Two Sigma Advisers LP	15,719	$25K	0.0%	-61.7%	0.041%
5/15/2023	Rubric Capital Management LP	1,487,385	$2.37M	0.1%	+11.8%	3.872%
5/12/2023	Renaissance Technologies LLC	125,299	$0.20M	0.0%	-10.4%	0.326%
5/12/2023	Bank of America Corp DE	23,241	$37K	0.0%	+81.3%	0.061%
5/12/2023	Dimensional Fund Advisors LP	124,431	$0.20M	0.0%	-30.7%	0.324%
5/10/2023	MAI Capital Management	379,468	$0.60M	0.0%	-11.1%	0.988%
5/8/2023	Bailard Inc.	19,900	$32K	0.0%	N/A	0.052%
4/4/2023	Trust Co. of Toledo NA OH	28,000	$45K	0.0%	N/A	0.073%
2/15/2023	Jane Street Group LLC	24,201	$35K	0.0%	N/A	0.063%
2/15/2023	Virtu Financial LLC	19,568	$29K	0.0%	N/A	0.051%
2/15/2023	Millennium Management LLC	198,904	$0.29M	0.0%	+32.3%	0.521%
2/14/2023	Two Sigma Investments LP	59,774	$87K	0.0%	N/A	0.156%
2/13/2023	Renaissance Technologies LLC	139,787	$0.20M	0.0%	+45.8%	0.366%
2/13/2023	Geode Capital Management LLC	224,438	$0.33M	0.0%	+3.0%	0.588%
2/9/2023	Dimensional Fund Advisors LP	179,621	$0.26M	0.0%	+22.7%	0.470%
2/9/2023	MAI Capital Management	426,916	$0.62M	0.0%	-33.0%	1.118%
11/15/2022	Vanguard Group Inc.	1,114,368	$4.76M	0.0%	+22.8%	2.917%
11/15/2022	BlackRock Inc.	662,600	$2.83M	0.0%	+22.2%	1.735%
11/14/2022	Cubist Systematic Strategies LLC	22,371	$96K	0.0%	+65.5%	0.060%
11/14/2022	Ergoteles LLC	132,636	$0.57M	0.0%	-14.7%	0.353%
11/14/2022	Rubric Capital Management LP	994,801	$4.25M	0.2%	N/A	2.649%
11/10/2022	Dimensional Fund Advisors LP	146,331	$0.63M	0.0%	N/A	0.390%
11/8/2022	Hamilton Lane Advisors LLC	35,791	$0.15M	0.1%	-49.9%	0.095%
8/18/2022	Goldman Sachs Group Inc.	204,164	$0.79M	0.0%	+35.5%	0.544%
8/15/2022	Occudo Quantitative Strategies LP	14,450	$56K	0.0%	-26.3%	0.038%
8/15/2022	State Street Corp	59,067	$0.23M	0.0%	-90.0%	0.157%
8/15/2022	Cubist Systematic Strategies LLC	13,517	$52K	0.0%	N/A	0.036%
8/15/2022	Laurion Capital Management LP	698,000	$2.71M	0.0%	N/A	1.858%
8/15/2022	Millennium Management LLC	316,309	$1.23M	0.0%	N/A	0.842%
8/13/2022	Renaissance Technologies LLC	93,399	$0.36M	0.0%	+94.6%	0.249%
8/12/2022	Northern Trust Corp	33,527	$0.13M	0.0%	-88.0%	0.089%
8/12/2022	Ensign Peak Advisors Inc	63,406	$0.25M	0.0%	+4.8%	0.169%
8/12/2022	Franklin Resources Inc.	29,386	$0.11M	0.0%	-32.6%	0.078%
7/20/2022	Clear Harbor Asset Management LLC	25,000	$97K	0.0%	N/A	0.067%
7/19/2022	MAI Capital Management	647,950	$2.51M	0.0%	+70.2%	1.728%
6/7/2022	Bank of America Corp DE	31,472	$0.15M	0.0%	-52.5%	0.084%
5/17/2022	Gilder Gagnon Howe & Co. LLC	182,396	$0.87M	0.0%	-15.0%	0.487%
5/16/2022	Goldman Sachs Group Inc.	150,689	$0.72M	0.0%	-21.6%	0.402%
5/16/2022	State Street Corp	588,603	$2.80M	0.0%	+2.3%	1.570%
5/13/2022	Renaissance Technologies LLC	48,000	$0.23M	0.0%	-58.5%	0.128%
5/13/2022	Northern Trust Corp	278,626	$1.33M	0.0%	-5.1%	0.743%
5/13/2022	Charles Schwab Investment Management Inc.	79,118	$0.38M	0.0%	-8.1%	0.211%
5/13/2022	Vanguard Group Inc.	828,877	$3.95M	0.0%	-43.0%	2.211%
5/12/2022	BlackRock Inc.	2,312,908	$11.01M	0.0%	-2.4%	6.170%
5/11/2022	Veritable L.P.	24,836	$0.12M	0.0%	N/A	0.066%
5/10/2022	MAI Capital Management	380,788	$1.81M	0.0%	N/A	1.016%
2/25/2022	AlphaCentric Advisors LLC	90,000	$0.33M	0.1%	N/A	0.241%
2/11/2022	Ensign Peak Advisors Inc	60,515	$0.22M	0.0%	N/A	0.162%
2/8/2022	ProShare Advisors LLC	13,174	$49K	0.0%	N/A	0.035%
2/8/2022	Northern Trust Corp	293,492	$1.07M	0.0%	-2.8%	0.787%
1/28/2022	Allspring Global Investments Holdings LLC	73,011	$0.27M	0.0%	N/A	0.196%
11/16/2021	Janus Henderson Group PLC	249,686	$2M	0.0%	-20.4%	0.669%
11/16/2021	Metropolitan Life Insurance Co NY	5,766	$46K	0.0%	-48.8%	0.015%
11/15/2021	Royal Bank of Canada	182,319	$1.46M	0.0%	-6.3%	0.490%
11/15/2021	Franklin Resources Inc.	43,618	$0.35M	0.0%	N/A	0.117%
11/15/2021	Jasper Ridge Partners L.P.	92,939	$0.75M	0.0%	N/A	0.250%
11/12/2021	Jump Financial LLC	21,852	$0.18M	0.0%	N/A	0.059%
11/12/2021	Oppenheimer & Co. Inc.	38,037	$0.31M	0.0%	N/A	0.102%
11/12/2021	Geode Capital Management LLC	481,301	$3.86M	0.0%	+7.1%	1.293%
11/10/2021	Goldman Sachs Group Inc.	171,194	$1.37M	0.0%	-34.5%	0.460%
11/10/2021	Citigroup Inc.	4,206	$34K	0.0%	+109.6%	0.011%
11/9/2021	Bourgeon Capital Management LLC	18,750	$0.15M	0.0%	+3,650.0%	0.050%
11/9/2021	BlackRock Inc.	2,085,048	$16.72M	0.0%	+1.2%	5.600%
11/8/2021	State Board of Administration of Florida Retirement System	10,068	$81K	0.0%	N/A	0.027%
11/5/2021	Advisor Group Holdings Inc.	4,999	$39K	0.0%	N/A	0.013%
11/2/2021	New York State Common Retirement Fund	22,055	$0.18M	0.0%	-28.9%	0.059%
11/1/2021	SG Americas Securities LLC	20,454	$0.16M	0.0%	N/A	0.055%
10/22/2021	Spire Wealth Management	3,698	$30K	0.0%	-48.1%	0.010%
10/14/2021	Hamilton Lane Advisors LLC	71,491	$0.57M	0.1%	N/A	0.192%
8/17/2021	Samsara BioCapital LLC	711,039	$8.06M	1.0%	-14.5%	1.917%
8/17/2021	Metropolitan Life Insurance Co NY	11,260	$0.13M	0.0%	N/A	0.030%
8/17/2021	MetLife Investment Management LLC	14,707	$0.17M	0.0%	N/A	0.040%
8/17/2021	Bridgeway Capital Management LLC	50,000	$0.57M	0.0%	N/A	0.135%
8/16/2021	Opaleye Management Inc.	257,189	$2.92M	0.5%	+148.3%	0.693%
8/16/2021	California State Teachers Retirement System	49,982	$0.57M	0.0%	N/A	0.135%
8/16/2021	Kettle Hill Capital Management LLC	185,065	$2.10M	0.4%	N/A	0.499%
8/16/2021	Royal Bank of Canada	194,526	$2.21M	0.0%	+9,426.2%	0.524%
8/16/2021	Charles Schwab Investment Management Inc.	83,792	$0.95M	0.0%	N/A	0.226%
8/16/2021	State Street Corp	484,222	$5.49M	0.0%	N/A	1.305%
8/16/2021	Nuveen Asset Management LLC	147,734	$1.68M	0.0%	N/A	0.398%
8/16/2021	Goldman Sachs Group Inc.	261,513	$2.97M	0.0%	-56.7%	0.705%
8/13/2021	Northern Trust Corp	313,350	$3.55M	0.0%	+2,273.5%	0.845%
8/13/2021	QS Investors LLC	43,618	$0.50M	0.0%	N/A	0.118%
8/13/2021	Geode Capital Management LLC	449,236	$5.09M	0.0%	+667.5%	1.211%
8/13/2021	Vanguard Group Inc.	1,433,922	$16.26M	0.0%	+589.2%	3.866%
8/13/2021	Bailard Inc.	145,000	$1.64M	0.1%	+291.9%	0.391%
8/12/2021	Trexquant Investment LP	10,339	$0.12M	0.0%	N/A	0.028%
8/12/2021	Legal & General Group Plc	3,098	$35K	0.0%	N/A	0.008%
8/12/2021	JPMorgan Chase & Co.	13,919	$0.16M	0.0%	N/A	0.038%
8/12/2021	The Manufacturers Life Insurance Company	21,875	$0.25M	0.0%	N/A	0.059%
8/11/2021	Bank of New York Mellon Corp	98,295	$1.12M	0.0%	N/A	0.265%
8/11/2021	BlackRock Inc.	2,061,171	$23.38M	0.0%	+1,006.2%	5.557%
8/11/2021	Deutsche Bank AG	21,524	$0.24M	0.0%	N/A	0.058%

Data available starting January 2016

Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. The company's development pipeline also includes vecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor; and VRx-510, a preclinical-stage PDK-1 inhibitor. The company was formerly known as Sunesis Pharmaceuticals, Inc. and changed its name to Viracta Therapeutics, Inc. in February 2021. Viracta Therapeutics, Inc. was incorporated in 1998 and is headquartered in Cardiff-by-the-Sea, California.

Today's Range

Now: $0.49

$0.46

$0.53

50 Day Range

MA: $0.70

$0.49

$1.09

52 Week Range

Now: $0.49

$0.44

$2.47

Volume

185,330 shs

Average Volume

133,543 shs

Market Capitalization

$18.89 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Who are the company insiders with the largest holdings of Viracta Therapeutics?: Viracta Therapeutics' top insider investors include:
Ivor Royston (CEO)
Daniel R Chevallard (CFO)
Lisa Rojkjaer (Insider)
Learn More about top insider investors at Viracta Therapeutics.
Who are the major institutional investors of Viracta Therapeutics?: Viracta Therapeutics' top institutional investors include:
Acadian Asset Management LLC — 0.25%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Viracta Therapeutics stock.
Which major investors are selling Viracta Therapeutics stock?: During the last quarter, VIRX stock was sold by these institutional investors:
Acadian Asset Management LLC
In the last year, company insiders that have sold Viracta Therapeutics company stock include:
Ivor Royston (CEO)
Daniel R Chevallard (CFO)
Learn More investors selling Viracta Therapeutics stock.